Cargando…
Suppression of Her2/neu expression through ILK inhibition is regulated by a pathway involving TWIST and YB-1
In a previous study it was found that the therapeutic effects of QLT0267, a small molecule inhibitor of integrin-linked kinase (ILK), were influenced by Her2/neu expression. To understand how inhibition or silencing of ILK influences Her2/neu expression, Her2/neu signaling was evaluated in six Her2/...
Autores principales: | Kalra, J, Sutherland, B W, Stratford, A L, Dragowska, W, Gelmon, K A, Dedhar, S, Dunn, S E, Bally, M B |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3007675/ https://www.ncbi.nlm.nih.gov/pubmed/20838384 http://dx.doi.org/10.1038/onc.2010.366 |
Ejemplares similares
-
QLT0267, a small molecule inhibitor targeting integrin-linked kinase (ILK), and docetaxel can combine to produce synergistic interactions linked to enhanced cytotoxicity, reductions in P-AKT levels, altered F-actin architecture and improved treatment outcomes in an orthotopic breast cancer model
por: Kalra, Jessica, et al.
Publicado: (2009) -
New Perspectives on the Role of Integrin-Linked Kinase (ILK) Signaling in Cancer Metastasis
por: McDonald, Paul C., et al.
Publicado: (2022) -
Using Pharmacokinetic Profiles and Digital Quantification of Stained Tissue Microarrays as a Medium-Throughput, Quantitative Method for Measuring the Kinetics of Early Signaling Changes Following Integrin-Linked Kinase Inhibition in an In Vivo Model of Cancer
por: Kalra, Jessica, et al.
Publicado: (2015) -
HER 2/neu protein expression in colorectal cancer
por: Schuell, B, et al.
Publicado: (2006) -
Integrin-linked kinase (ILK) and its interactors: a new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes
por: Wu, Chuanyue, et al.
Publicado: (2001)